India Globalization Capital appoints former Congressman Jim Moran to board of directors

IGC Pharma, Inc.

Appointed former Congressman Jim Moran as independent Class C director effective Jan 18, 2022.
Moran served Virginia's 8th District for 24 years; was on Appropriations, Banking, and Budget committees.
He received 150,000 RSUs: 50,000 vest immediately, remainder over 2 years.
Press release highlights Moran's expertise and IGC's Phase 2/3 Alzheimer's trial for IGC-AD1.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jim Moran

Class C director

IGC · IGC Pharma, Inc.

Effective: 2022-01-18
Filed: January 18, 2022, 6:59 PM ET

On January 18, 2022, the Board of Directors (the “Board”) of India Globalization Capital Inc. (the “Company” or “IGC”) appointed former Congressman Jim Moran (“Congressman Moran”) to serve on the Board as a Class C director.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jim Moran was appointed as Class C director at IGC Pharma, Inc..

Action: appointed
Role: Class C director

Exact text from the filing

On January 18, 2022, the Board of Directors (the “Board”) of India Globalization Capital Inc. (the “Company” or “IGC”) appointed former Congressman Jim Moran (“Congressman Moran”) to serve on the Board as a Class C director.

View on SEC.gov

IGC Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-22-000067

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.